Advanced Pharma CR, LLC (Site 0001)

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes1 trial

Phase

• Phase 13 trials

Status

• Completed3 trials

Lead sponsor

• Merck Sharp & Dohme LLC3 trials

Closed trials

• Completed

  Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)

  NCT07089784· Phase 1· Merck Sharp & Dohme LLC· Source

• Completed

  A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

  NCT06052566· Phase 1· Merck Sharp & Dohme LLC· Source

• Completed

  Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Renal Impairment Study (MK-0616-020)

  NCT05934292· Phase 1· Merck Sharp & Dohme LLC· Source